Anaplastic Lymphoma Kinase Positive Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Anaplastic Lymphoma Kinase Positive Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib [Phase 2]
Phase 2 study evaluating brigatinib in patients with anaplastic lymphoma kinase–positive advanced non-small cell lung cancer that progressed…